Empowering Laboratories of the Future: The Urgent Need for Clinical Context

InterSystemsOpinion Article by Martin Wilkinson, Director of Product Introduction, Strategy and User Adoption at InterSystems.
Laboratories across the world still work largely in isolation to clinical providers. Even today, in the digital age of sharing information, a large majority of laboratory professionals are not given the full clinical perspective on the very patients they are carrying out tests for, something that must change with urgency.

Diagnostic functions working within and alongside our health services need to be given clinical context and access to wider sets of information, so that laboratory professionals, like pathologists, can make active and effective decisions on testing and not just rely on inadequate and even sketchy requests from clinical colleagues in different care settings.

It is time to move the laboratory out of the back office, to become a core element of clinical delivery.

Why laboratories do not have the full clinical picture
Laboratories today still often look at their data in isolation. One reason behind this is that information systems have traditionally been niche market solutions specific to the laboratory, meaning that they have become silos of information, locked away from the frontline of healthcare.

Professionals working in diagnostics can only act on information they have, which is often limited and sometimes even flawed. One major contributing factor to this problem can be found in examination requests themselves, which are too often populated with handwritten notes that need to be interpreted and then transcribed into the system.

Hindrance too is caused by order systems which present limited information onscreen. A professional might see that the patient they are testing for is anaemic, or that they are bleeding from a wound, but they are often not aware of the full clinical picture. So by being able to provide information on previous testing, along with the patient's clinical symptoms as well as their current drug therapy, this can influence the interpretation of the laboratory results without delays having to be incurred by conducting further investigative processes.

Inappropriate testing and delays in care we cannot afford
For as long as the clinical picture is absent from the laboratory, there is the potential for the most relevant testing to be missed within an initial request.

Take a scenario: The clinician on the ward, or in the clinic, receives the report they requested and realises that they needed to request an additional test to that which was ordered. A new test is then subsequently ordered. The patient may then need to have another sample taken, which is sent again to the laboratory for retesting. A new report is written and sent to the doctor to make a decision.

This extended process can result in unnecessary increased lengths of stay, delays in clinical decisions, and inappropriate repeat tests and samples being taken from patients. At a time when healthcare budgets are under pressure, it is expensive to keep people in beds, it is costly to repeat tests and there is additional burden placed on precious resource that we cannot afford to waste. Arguably, and most importantly, there is the risk of delay in the diagnosis of the patient.

Doctors can also choose to request a battery of different tests in an attempt to cover everything - leading to further increased cost of care and unnecessary pressure on scarce laboratory resources.

The objective must be to achieve availability of relevant clinical information at the point of analysis and decision making as quickly as possible.

The right clinical indicators for the right tests
Given the right information, professionals in the laboratory have the expertise to know when tests are needed and when they are not. In a clinical investigation for deep vein thrombosis, the Wells score can be used as a guide to the clinician to assess the clinical risk of such a clinical condition and provide direction on whether additional testing is needed. However, there may be a lack of visibility of the Wells score for professionals in the laboratory.

If they had access to the score, laboratory professionals would be able to make the decision as to whether or not to make those additional tests, at the point the initial sample was received. Instead, they can all too often only perform the tests that have been requested by the clinician, which can result in the cumbersome re-testing process described earlier.

All of this can be eliminated if that clinical indicator is available to the laboratory at the initial point of testing.

Demand systems and a lack of prompts and guidance for appropriate testing at the point of care can cause similar problems. In the case of a cardiac arrest, for example, there is a need to measure Troponin, and for this and other conditions it is important to use clinical best practice guidelines available as to the indicators for retesting.

However, if the clinician does not have access to guidelines and demand management tools at the point of order, the patient will often have their sample taken multiple times, which the laboratory is then obliged to test. This means that this process is often completed regardless of the potential inappropriate nature of the test, increasing the cost of the clinical laboratory services and use of time and human resources.

We need to build rules into the ordering process, assist clinicians, but most importantly, we need to empower the diagnostic professionals within the laboratory in order to overcome such challenges.

Taking the laboratory out of the back office to the frontline of clinical care
The urgency for change is critical, particularly now with the increasing demand on our healthcare services. To achieve this we must take laboratory systems away from being islands, a back office function and a support for clinicians, to a more clinical, front of house, engaged clinical service. And by creating this change, pathologists can be provided with the information they require, along with clinical indicators, to make decisions as to when appropriate tests are required for patients.

This is about communication between the various points of care, and recognising the diagnostic function as a key clinical contributor. By empowering laboratory professionals with clinical information, we can change who plays a clinical role. This will not only save time, but make the clinical process at the patient point of care more effective.

Evolving sources of information need to be considered too in this changing role of the modern laboratory, as also taking place is a rapid evolution of a point of care testing. The next generation of laboratory systems must integrate with new care devices and wearable technologies. Wearables can be used to measure a growing range of variables in the human body. If a wearable can be used to measure blood glucose levels, there is no reason why that valuable information should not feed into a diabetic patient's clinical record, for example.

There is finite capacity in the laboratory. If we can stop patients being unnecessarily re-tested, then the laboratory will have more capacity to focus on core tasks. The consequence is a less stretched environment where both the quality and relevance of the output improves.

Benefits for the patient
Patients too can benefit from placing the laboratory at the centre of care, and not just from the perspective of avoiding unnecessary blood tests. Convenience does play a part, and unnecessary repeat tests can be a hindrance to busy lives. But more importantly, effective intervention often means timely intervention. We want to produce the best outcomes we can for our patients.

Equally, avoiding any unnecessary distress for patients should be a consideration for any healthcare service. If a patient has a blood test and is called back for another, they can fear the worst in terms of their own health.

Ending the diagnostic disconnect
At a time when healthcare services are striving to save billions of pounds, improve patient safety and deliver the best outcomes for patients, speedy, efficient and effective laboratory testing is essential. Achieving the highly sought new models of care outlined in many national strategies, means empowering the right people to make the best decisions for patients at every point of care.

To do this, laboratory professionals must be given access to the right clinical information with urgency in order to transform diagnostics, so that laboratory professionals can take decisive action for patients at the earliest possible opportunity. The current disconnect between clinical settings and our laboratories must come to an end, and this is achievable through the application of new systems and process that are now available.

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...

New Computer Models Open Door to Far Mor…

With antibiotic resistance a growing problem, University of Virginia School of Medicine researchers have developed cutting-edge computer models that could give the disease-fighting drugs a laser-like precision to target only...

New Biomarkers to Detect Colorectal Canc…

Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of Birmingham researchers to discover proteins that have strong predictive potential for colorectal cancer. In a...

Sam Neville Joins the Highland Marketing…

Leading chief nursing information officer Sam Neville is joining the Highland Marketing advisory board. Sam brings a passion for nursing and safety to the board, which debates the big issues...